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While it is now acknowledged that CD4+ T cells expressing CD25 and Foxp3 (Treg
cells) regulate immune responses and, consequently, influence the pathogenesis of
infectious diseases, the regulatory response mediated by Treg cells upon infection by
Trypanosoma cruzi was still poorly characterized. In order to understand the role of Treg
cells during infection by this protozoan parasite, we determined in time and space the
magnitude of the regulatory response and the phenotypic, functional and transcriptional
features of the Treg cell population in infected mice. Contrary to the accumulation of
Treg cells reported in most chronic infections in mice and humans, experimental T. cruzi
infection was characterized by sustained numbers but decreased relative frequency of
Treg cells. The reduction in Treg cell frequency resulted from a massive accumulation
of effector immune cells, and inversely correlated with the magnitude of the effector
immune response as well as with emergence of acute immunopathology. In order
to understand the causes underlying the marked reduction in Treg cell frequency,
we evaluated the dynamics of the Treg cell population and found a low proliferation
rate and limited accrual of peripheral Treg cells during infection. We also observed
that Treg cells became activated and acquired a phenotypic and transcriptional profile
consistent with suppression of type 1 inflammatory responses. To assess the biological
relevance of the relative reduction in Treg cells frequency observed during T. cruzi
infection, we transferred in vitro differentiated Treg cells at early moments, when the
deregulation of the ratio between regulatory and conventional T cells becomes significant.
Araujo Furlan et al. Treg Cells Dampen Parasite-Specific Immunity
Intravenous injection of Treg cells dampened parasite-specific CD8+ T cell immunity and
affected parasite control in blood and tissues. Altogether, our results show that limited
Treg cell response during the acute phase of T. cruzi infection enables the emergence of
protective anti-parasite CD8+ T cell immunity and critically influences host resistance.
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INTRODUCTION
Regulatory T (Treg) cells, defined by the expression of the lineage
transcription factor forkhead box P3 (Foxp3), are able to suppress
most immune cells (1) and their suppressive function is crucial
for immune homeostasis and prevention of autoimmunity (2). In
addition, Treg cells were shown to be critical mediators in the
modulation of host-microbe interaction during infections and to
play beneficial or deleterious roles in host resistance (3). Several
chronic bacterial infections, such as tuberculosis (4) and leprosy
(5) promote the accumulation and preferential migration of Treg
cells to target tissues, where these cells exert regulatory effects that
compromise protective responses and favor bacterial persistence
(6). During viral infections, the role of this cell subset appears
to be different between acute and chronic infections and even to
change during the same infection with the transition from acute
to chronic stages. In this way, Treg cells have been shown to
coordinate early protective immunity to mucosal Herpes Simplex
Virus (7, 8) and pulmonary Respiratory Syncytial Virus (9, 10),
and to sustain memory CD8+ T cell immunity toWest Nile virus
(11). In contrast, there is by far more evidence that Treg cells
accumulate during certain viral infections and dampen adaptive
immune responses, specially CD8+ T cell immunity, promoting
virus establishment and infection chronicity (12, 13). Thus, Treg
cells seem to exert a general beneficial role by limiting exuberant
immune responses and the consequent excessive inflammation
and immunopathology even at the expense of reducing viral
control (12, 14, 15). Similar scenarios have been reported in the
course of parasitic infections (16). During leishmaniasis (17) and
malaria (18), Treg cells have been shown to limit the magnitude
of effector responses, resulting in failure to adequately control
infection (19–21). In contrast, these cells favor host resistance
during infections with S. mansoni and T. gondii by restraining
collateral tissue damage caused by vigorous anti-parasite immune
responses (22–24). In addition, relative or absolute reduction
in Treg cell numbers during acute infections with T. gondii
(23, 25), L. monocitogenes (25), vaccinia virus (25) and LCMV
clone Armstrong (26) supports the emergence of CD4+ and
CD8+ T cell immunity. Therefore, the impact of Treg cells
in the outcome of an infection is expected to be different
depending on the pathogen, timing and affected tissues, while
their manipulation may open up new avenues for therapeutic
strategies.
Chagas disease (American Trypanosomiasis) is a life-
threatening illness caused by the protozoan parasite T. cruzi
(27). Last estimates calculated an infected population of about 6
million in endemic areas of Latin America and several hundred
thousand worldwide, with more than 70 million people living at
risk of infection and 40,000 new cases diagnosed per year (28).
Host resistance to T. cruzi depends on both innate and adaptive
immune responses which are triggered early during infection
(29–31). Macrophages, dendritic cells, natural killer cells and B
and T lymphocytes act in concert to control parasite replication
but are not able to completely eradicate the pathogen (32).
In particular, parasite-specific antibodies and CD8+ T cells
together with a type I response with production of IFN-γ
and TNF are critical for host resistance (32). Nevertheless,
exuberant production of these inflammatory cytokines has been
associated with tissue damage, immunopathology and disease
severity in mice and humans (33–36), supporting the notion
that regulatory responses greatly impact in the final outcome
of T. cruzi infection. In this context, many studies aimed to
understand the role of Treg cells during the progression of
this parasitic infection, reporting often contradictory results.
The frequency and functionality of Treg cells were shown
to be increased in the peripheral blood of infected patients
that presented less severe chronic disease (37–40), suggesting
a beneficial role for this cell subset during human Chagas
disease. On the other hand, experimental models reported
protective (41, 42), limited (43, 44) and also deleterious (45)
effects for Treg cells during T. cruzi infection. However, none
of these studies addressed the kinetics or the phenotypical
and functional features of the regulatory response, and more
importantly, all of them targeted Treg cells by non-specific
approaches. These technical limitations have delayed an accurate
characterization of Treg cell responses during T. cruzi infection
and, therefore, prevented any rational manipulation of this
subset in order to modulate the outcome of the chronic
disease.
In this manuscript, we took advantage of Foxp3-EGFP
reporter mice to comprehensively determine the magnitude and
quality of the Treg cell response triggered by T. cruzi infection. In
addition, adoptive transfer experiments of in vitro differentiated
Treg cells allowed us to establish the biological role of this subset
in the regulation of protective immunity and parasite control.
MATERIALS AND METHODS
Mice
Mice used for experiments were sex- and age-matched.
C57BL/6 and BALB/c wild type mice were obtained from
School of Veterinary, La Plata National University (La Plata,
Argentina). CD45.1 C57BL/6 mice (B6.SJL-Ptprca Pepcb/BoyJ),
Foxp3-EGFP reporter mice (B6.Cg-Foxp3tm2Tch/J), IL-6 deficient
mice (B6.129S2-Il6tm1Kopf/J) and Caspase-1/11 deficient mice
(B6N.129S2-Casp1tm1Flv/J) were obtained from The Jackson
Laboratories (USA). IFNAR deficient mice (Ifnar1tm1Ag) were
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obtained from Pasteur Institute (Paris, France) (46). Animals
were bred in the animal facility of the Facultad de Ciencias
Químicas, Universidad Nacional de Córdoba, and housed under
a 12 h: 12 h light-dark cycle with food and water ad libitum.
Parasites and Experimental Infection
Bloodstream trypomastigotes of the Tulahuén strain of T. cruzi
were maintained in BALB/c mice by serial passages each 10–
11 days. For experimental infection, 7–10 weeks-old mice were
inoculated intraperitoneally with 0.2ml PBS containing 5 ×
103 trypomastigotes. Alternatively, doses of 500 and 5 × 104
trypomastigotes were used as indicated.
Live T. cruzi trypomastigotes (Tulahuén) were obtained from
the extracellular medium of infected monolayers of Vero cells, as
previously described (47).
Quantification of Parasite Numbers in
Blood and Parasite Burden in Tissues
Parasitemia was monitored by counting the number of viable
trypomastigotes in blood after lysis with a 0.87% ammonium
chloride buffer. Abundance of T. cruzi satellite DNA in
tissues was used to determine parasite burden. Genomic DNA
was purified from 50 µg of tissue (spleen and liver) using
TRIzol Reagent (Life Technologies) following manufacturer’s
instructions. Satellite DNA from T. cruzi (GenBank AY520036)
was quantified by real time PCR using specific Custom
Taqman Gene Expression Assay (Applied Biosystem). Primers
and probes sequences were previously described by Piron
et al (48). A sample was considered positive for T. cruzi
target when CT < 45. Abundance of satellite DNA from T.
cruzi was normalized to GAPDH abundance (Taqman Rodent
GAPDH Control Reagent, Applied Biosystem), quantified
through the comparative CT method and expressed as arbitrary
units.
Cell Preparation, Purification, and Culture
Blood was collected using heparin as anticoagulant. Spleens,
thymi, livers and mesenteric and inguinal lymph nodes were
obtained and pressed through a tissue strainer to obtain cell
suspensions. Bone marrow cells were isolated by flushing femurs
and tibias with PBS 2% FBS. Liver infiltrating cells were
obtained after 25min centrifugation (600 g) in a 35 and 70%
bilayer of Percoll (GE Healthcare) gradient. Erythrocytes in bone
marrow, spleen, thymus and liver cell suspensions were lysed
for 3min in ammonium chloride-potassium phosphate buffer.
Cell numbers were counted in Turk’s solution using a Neubauer
chamber.
CD4+ and CD8+ T cells were isolated from pooled splenic
suspensions by magnetic negative selection using EasySepTM
Mouse CD4+ or CD8+ T Cell Isolation Kits, respectively
(StemCell Technologies). After surface staining, Treg, Tconv
and naïve CD4+ T cells were further purified from CD4+
T cell suspensions by cell sorting with a FACSAria II (BD
Biosciences) using the following gating strategy: Treg cells:
CD4+ Foxp3-GFP+ CD25int/hi; Tconv cells: CD4+ Foxp3-
GFP− CD25−/+; and naïve CD4+ T cells: CD4+ Foxp3-GFP−
CD25− CD62Lhi CD44lo. Cells were cultured in RPMI 1640
medium (Gibco, Invitrogen) supplemented with 2mMglutamine
(Gibco, Invitrogen), 55µM 2-ME (Gibco, Invitrogen), and
40µg/ml gentamicin (Veinfar Laboratories) containing 10% heat
inactivated FBS (Gibco or Natocor).
For in vitro Treg cell differentiation, naïve CD4+ T cells
or total splenocytes were stimulated at a cell density of 2
× 105/well during 3–4 days in 96-well cell culture plates
coated with 2µg/mL anti-CD3 (eBioscience) and 1µg/mL anti-
CD28 (BD Biosciences), in presence or absence of a Treg cell
differentiation cocktail containing 100 U/mL mrIL-2 (RandD),
5 ng/mL rTGF-β1 (eBioscence) and 13.3 nM all trans-Retinoic
Acid (Sigma). In the experiments aimed to evaluate the inhibition
of Treg cell induction, live T. cruzi parasites were added in
different ratios as described in the corresponding legend for
figure.
Biochemical Determinations and
Quantification of Cytokines in Plasma
Blood was centrifuged for 8min at 3,000 rpm and plasma
was collected. Plasma samples were sent to Biocon Laboratory
(Córdoba, Argentina) for quantification of GOT, GPT, LDH and
CPK by UV kinetic methods, and glucose by kinetic/colorimetric
method in a Dimension RXL Siemens analyzer. Plasma levels
of different cytokines were determined in our laboratory using
LEGENDplexTM Multi-Analyte Flow Assay Kit (Biolegend) for
Mouse Th Cytokine and Inflammation Panels according to
manufacturer’s instructions.
Antibodies and Flow Cytometry
For surface staining, cell suspensions were incubated with
fluorochrome labeled-antibodies in PBS 2% FBS for 20min at
4◦C. Flow cytometry and/or cell sorting were performed with a
combination of the following antibodies: anti-CD4 APC, APC-
eFluor-780 or PerCP-eFluor 710 (all clone GK1.5), anti-CD25
PE-Cy7 (P61.5), anti-CD3 PerCP-Cy5.5 (145-2C11), anti-CD8a
FITC, PE, PE-Cy7 or PerCP-Cy5.5 (53-6.7), anti-CCR7 PerCP-
Cy5.5 (4B2), anti-CD103 PE (2-E7), anti-CD127 PerCP-eFluor-
710 (eBioSB/199), anti-CD39 eFluor-660 (24DMS1), anti-CD44
APC-Cy7 (IM7), anti-CD45.2 PerCP-Cy5.5 (104), anti-CD62L
PerCP-Cy5.5 (MEL-14), anti-CD73 biotin (eBioTY/11-8), anti-
CTLA-4 PE (UC10.4B9), anti-CXCR3 PE (CXCR3-173), anti-
FR4 PE (eBio12a5), anti-GARP APC (YGIC86), anti-OX40 APC
(OX-86) and anti-PD-1 PE (RMP1-30) from eBioscience; anti-
CD4 AlexaFluor700 (GK1.5), anti-CD45.1 APC-Cy7 (A20), anti-
GITR PE-Cy7 (DTA-1), anti-LAG-3 PerCP-Cy5.5 (C9B7W),
anti-KLRG1 PE (2F1/KLRG) and anti-LAP PE (TW7-20B9)
from Biolegend; and anti-CD127 biotin (B12-1) from BD
Biosciences. To detect biotinilated antibodies, Streptavidin APC
(Biolegend) or PerCP-Cy5.5 (eBioscience) were used. To identify
T. cruzi specific CD8+ T cells, cell suspensions were incubated
with an H-2Kb T. cruzi trans-sialidase amino acids 569-576
ANYKFTLV (TSKB20) APC-labeled Tetramer (NIH Tetramer
Core Facility) for 20min at 4◦C before further surface staining
with additional antibodies. Blood was directly incubated with
the indicated antibodies and erythrocytes were lysed with
a 0.87% NH4Cl buffer previously to acquisition. To assess
apoptosis, cells were stained for Annexin V PE (Biolegend)
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and 7-AAD (BD Biosciences) according to the manufacturer’s
specifications.
For detection of transcription factors, cells were first stained
on surface, washed and then fixed, permeabilized and stained
with Foxp3/Transcription Factor Staining Buffers (eBioscience)
according to eBioscience One-step protocol for intracellular
(nuclear) proteins. The following antibodies were used for
intracellular staining: anti-Foxp3 PE, PerCP-Cy5.5 or APC (FJK-
16s), anti-T-bet PerCP-Cy5.5 or PE-Cy7 (eBio4B10), and anti-Ki-
67 APC (SolA15) from eBioscience.
For intracellular cytokine staining, 2 × 106 cells per well
were cultured in 200 µL supplemented RPMI 1640 medium
and stimulated during 2–5 h at 37◦C with 50 ng/mL PMA
and 1µg/mL ionomycin (Sigma-Aldrich) in the presence of
Brefeldin A and/or Monensin (eBioscience). After surface
staining, cells were fixed and permeabilized with Intracellular
Fixation & Permeabilization Buffer Set (eBioscience) or BD
Cytofix/Cytoperm and Perm/Wash (BD Biosciences) following
manufacturers’ indications. Cells were then labeled with anti-IL-
10 APC (JES5-16E3), anti-IFN-γ APC or PE (XMG1.2) and anti-
IL-17A PE (eBio17B7) from eBioscience; anti-IL-10 PE (JES5-
16B3) and anti-TNF PerCP-Cy5.5 (MP6-XT22) from Biolegend.
All samples were acquired on a FACSCanto II (BD
Biosciences) and data were analyzed with FlowJo software.
Adoptive Cell Transfer
For in vivo pTreg cells induction experiments, Tconv cells
were purified from non-infected Foxp3-EGFP CD45.2 donors
as described above. Two millions cells were then intravenously
injected in the retro-orbital sinus of CD45.1 recipient mice,
which were simultaneously infected with the usual dose of T.
cruzi. Non-infected and/or non-transferred mice were used as
controls. Conversion of injected cells (Foxp3-GFP−) into Treg
cells (Foxp3-GFP+) was assessed by flow cytometry in different
organs 19 days after treatment.
To assess the biological relevance of reduced Treg cells
frequency, 1 × 106 in vitro differentiated Treg cells generated
from Foxp3-EGFP mice were intravenously transferred into
CD45.1 recipient mice at 11 days post-infection (dpi). The effect
of Treg cell adoptive transfer was evaluated 7 days later.
RNAseq
Treg cells were purified as described above from the spleens
of non-infected and 22-days infected Foxp3-EGFP mice and
immediately lysed with QIAzol reagent (Qiagen). Total RNA was
extracted by using the RNeasy Micro Kit (Qiagen) and its quality
was assessed on a 2100 Bioanalyzer (Agilent Technologies).
RNA-seq libraries were then prepared according to the TruSeq
Stranded Total RNA Sample protocol (Illumina). Quality
controls of the libraries were performed by standard methods,
including quantification by Qubit (Thermo Fisher Scientific)
and assessment of size distribution using a 2100 Bioanalyzer.
Samples were indexed and sequenced on an Illumina HiSeq 3000
(paired-end reads of 150 bp). Bioinformatic analysis of sequenced
Reads was performed as described elsewhere (49). P-values
<0.1 (adjusted for multiple testing by Benjamini–Hochberg
procedure) were considered as the cutoff for significantly
differentially expressed genes. Gene Set Enrichment Analyses
(GSEA) for Th1, Th2, and Th17 signature were performed
using specific gene sets selected from several publications as
indicated in Supplementary Table 1 and depicted in heat maps
of Figure 4E. NCBI Sequence Read Archive accession code:
SRP145339.
Statistics
Statistical significance of mean values comparisons was analyzed
by t-test, Mann Whitney test, One-way ANOVA or Kruskal-
Wallis test as indicated. According to the absolute values of r,
the Spearman correlation was interpreted as strong (r = 0.7–
0.9), good (r = 0.50–0.70), moderate (r = 0.30–0.50), and poor
(r < 0.30) (50–52). Statistical analysis was performed using
GraphPad Prism 7.0 software. P-values ≤0.05 were considered
significant.
RESULTS
Treg Cell Frequency Is Decreased During
the Progression of T. cruzi Infection
As an initial step to characterize Treg cell responses, we evaluated
how T. cruzi infection affected the frequency and absolute
numbers of Treg cells and other immune cell subsets. Using
Foxp3 reporter mice, we determined that acute T. cruzi infection
resulted in a significant decrease in the percentage of Treg
cells (CD4+ Foxp3-GFP+) in the spleen (Figure 1A). This
decrease in the frequency of splenic Treg cells was statistically
significant after 12 days post-infection (dpi) and remained low
even at the end of the acute phase (76 dpi; Figure 1B, left
panel). Of note, the absolute numbers of Treg cells remained
unchanged or were transiently increased at low extent while the
numbers of CD4+ Foxp3-GFP (Tconv) cells and total spleen
leukocytes were augmented by several orders of magnitude
(Figure 1B, middle panel). Consequently, the ratios between
the numbers of Treg cells and Tconv cells or total cells were
significantly decreased along the infection (Figure 1B, right
panel). A similar picture was observed in secondary lymphoid
organs, such as inguinal lymph nodes (iLN) (Figure 1C) as
well as in the liver, a target tissue with intense parasite
replication and immune cell infiltration during the acute phase
of T. cruzi infection (53) (Figure 1D). This reduction in the
frequency of Treg cells and/or the ratio of Treg cell numbers to
Tconv and total cell numbers were also detected in blood and
bone marrow (Supplementary Figures 1A,B). Altogether, these
results indicate that, in contrast to most chronic infections (6),
Treg cells do not significantly accumulate in secondary lymphoid
organs or liver during T. cruzi infection.
Next, we evaluated Treg cells frequencies and numbers in
organs associated with the development of this subset, e.g.,
thymus and gut-associated mesenteric lymph nodes (mLN) (54).
We determined that the percentage of Treg cells as well as
the ratio between the numbers of this population and other
cell subsets in the thymus were significantly increased during
T. cruzi infection (Supplementary Figure 1C, left and right
panels), likely as consequence of conserved Treg cells numbers
together with a marked reduction in the number of total
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FIGURE 1 | Frequency of Foxp3+ regulatory T cells is reduced in peripheral organs during acute T. cruzi infection. (A) Flow cytometry representative dot plots
showing Foxp3-GFP expression and CD4 staining in the spleen of T. cruzi infected Foxp3-EGFP mice at different days post-infection (dpi). (B–D) Graphs showing
CD4+ Foxp3-GFP+ Treg cell frequencies (left panel), absolute numbers of Treg cells, CD4+ Foxp3-GFP− (Tconv) cells and total leukocytes (middle panel), and the
ratios of Treg cells to Tconv and to total cells in the spleens (B), inguinal lymph nodes (C), and liver infiltrating leucocytes (D) of T. cruzi infected Foxp3-EGFP mice at
different dpi. Data are presented as mean ± SEM, n = 3–11 animals per dpi. Data are representative of at least three independent experiments. P-values were
calculated by One way ANOVA with Dunnett’s multiple comparisons test or Kruskal-Wallis with Dunn’s correction (Tconv and total cells absolute numbers in liver only).
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001.
thymocytes (Supplementary Figure 1C, middle panel). In mLN,
the numbers of Treg cells showed an initial oscillation (increase
followed by decrease) after infection while the frequency and
the ratio of Treg cells to Tconv numbers exhibited an early
increase, but all these parameters remained unaltered afterwards
(Supplementary Figure 1D).
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The Frequency of Treg Cells Is Negatively
Correlated With Markers of Infection
Progression and the Development of
Effector Immune Responses
We next aimed at studying whether the changes in the
frequency of Treg cells during T. cruzi infection showed any
correlation with disease progression and/or the magnitude
of effector immune responses. As markers of progression
in the infection by T. cruzi we evaluated parasitemia
and the levels of different biochemical parameters used
to assess general health and tissue damage. As depicted
in Figure 2A, parasite numbers in blood were low but
detectable at 12 dpi, peaked around 20 dpi, diminished by
34 dpi and became undetectable later on. Similar kinetics
was observed when measuring the activity of enzymes that
reflect tissue damage (i.e., GPT, LDH, GOT, and CPK;
Figure 2A, middle panel; Supplementary Figure 2A). In
contrast, the concentration of plasma glucose, whose decrease
is generally associated with acute infection (55), was reduced
alongside the progression of infection, showing the lowest
level around 20 dpi and reaching normal levels afterwards
(Figure 2A, right panel). Remarkably, changes in the levels
of all these parameters showed statistically significant strong,
good or moderate correlations with the frequencies of Treg
cells in the spleen (Figure 2B; Supplementary Figure 2B).
These correlations were direct for glucose concentration
and inverse for parasitemia and enzymatic activity
in plasma.
To assess the effector immune response, we quantified
the plasma concentration of effector cytokines known to be
protective during T. cruzi infection, such as IFN-γ and TNF
(32). The concentration of IFN-γ showed a marked increase
by 12 dpi and diminished later on, while the kinetics of
TNF production was slower, showing the peak of plasma
concentration at 20 dpi (Figure 2C). In addition, we quantified
other effector cytokines, such as IL-6, IL-1β, and IL-2. The
concentration of IL-6 was significantly increased by 12 dpi,
peaked at 20 dpi and decreased afterwards whereas the
concentrations of IL-1β and IL-2 remained unchanged along
the infection (Supplementary Figure 2C). The concentrations
of IFN-γ, TNF and IL-6, but not those of IL-1β and
IL-2, showed significant strong, good or moderate inverse
correlations with the frequency of Treg cells in spleen
(Figure 2D; Supplementary Figure 2D). We also evaluated the
presence of parasite-specific CD8+ T cell immunity as a
component of the cellular effector immune response known
to be critical for parasite control (31). CD8+ T cells specific
for the immunodominant T. cruzi peptide TSKB20 were
identified in the spleen of T. cruzi infected mice using
tetramers (Figure 2E). We found that the frequency and absolute
numbers of TSKB20-specific CD8+ T cells increased between
12 and 48 dpi (Figures 2E,F). Similar to effector cytokines,
the frequency of TSKB20-specific CD8+ T cells showed a
good inverse correlation with the frequency of Treg cells
(Figure 2G).
Limited Expansion and Reduced Accrual of
Peripheral Treg Cells During Acute T. cruzi
Infection
In steady state conditions, the size of the Treg cell population
is maintained by a dynamic process, through a balance among
development, proliferation and apoptosis (56). During infections,
these events may be altered leading to the accumulation,
constriction or dysfunction of Treg cells and consequently,
modulating the effector immune response and the host-microbe
interaction (57). In this context, we aimed to evaluate whether
the reduction of Treg cell frequency during T. cruzi infection was
a consequence of alterations in the mechanisms that sustain Treg
cell homeostasis.
We first evaluated the proliferation of splenic Treg cells, Tconv
and total leukocytes along T. cruzi infection by determining ex
vivo the expression of the proliferationmarker Ki-67. As depicted
in the histograms in Figure 3A, the frequency of Treg cells
expressing Ki-67 showed a moderate increase around 20–34 dpi
that persisted at least until 76 dpi. In contrast, the frequencies
of Ki-67+ Tconv and total cells were markedly augmented along
the infection with a peak at 20 dpi, returning to the level
of non-infected mice by 76 dpi. Thus, Treg cells showed a
significantly lower proliferation rate than Tconv and total cells
(Figure 3B). These differences in proliferation may account for
the reduced frequency of Treg cells during the early acute phase
of T. cruzi infection. Next, we evaluated whether differential cell
death within each cell subset may also be involved in Treg cell
frequency reduction during T. cruzi infection. Determination
of the frequency of apoptotic cells by Annexin V and 7-AAD
staining, and calculation of the apoptosis rate, revealed that
T. cruzi infection increased cell death particularly within the
Tconv population (Figures 3C,D), as previously reported (58).
Therefore, an increased cell death within Treg cells was ruled out
as a mechanism underlying the decrease in the frequency of this
cell subset during T. cruzi infection.
We next investigated whether infection with T. cruzi
restrained Treg cell development and consequently, reduced Treg
cell frequency in the periphery. Considering that the numbers
of Treg cells are conserved in the thymus of infected mice
(Supplementary Figure 1C), we speculated that thymic Treg
cell development was not significantly altered during T. cruzi
infection. Then, we focused on the development of peripheral
Treg (pTreg) cells through an in vivo approach in order to
evidence alterations triggered by T. cruzi infection. To this end,
CD25− GFP− CD4+ cells were purified from the spleen of non-
infected CD45.2+ Foxp3-GFP reporter mice and injected into
CD45.1 WT hosts that were immediately infected. Adoptively
transferred non-infected hosts were examined in parallel and
used as controls. Twenty days after injection, transferred cells
were identified by CD45.2 expression within different organs
and the frequency of pTreg was determined according to the
up-regulation of Foxp3 and CD25 expression. As illustrated in
Figure 3E, mLN from non-infected and infected hosts contained
a small percentage of injected cells. A high percentage (around
60%) of the injected cells within mLN from non-infected mice
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FIGURE 2 | Frequency of Treg cells inversely correlates with markers of acute disease progression and the emergence of effector immune responses. (A) Parasitemia
(left panel) in blood, activity of glutamate-pyruvate transaminase (GPT) (middle panel) and glucose concentration (right panel) in plasma of T. cruzi infected
Foxp3-EGFP mice at different dpi. (B) Scatter plots showing the relation between splenic Treg cell frequencies and each of the parameters shown in (A).
(C) Concentration of effector cytokines in plasma of T. cruzi infected Foxp3-EGFP mice at different dpi. (D) Scatter plots showing the relation between Treg cell
frequencies in the spleen and plasma level of effector cytokines. (E) Representative dot plots for CD8 and TSKB20/Kb staining in the spleen of T. cruzi infected
Foxp3-EGFP mice at different dpi. (F) Percentage (left) and absolute numbers (right) of parasite-specific CD8+ T cells in the spleen T. cruzi infected Foxp3-EGFP mice
at different dpi. (G) Scatter plots showing the relation between frequencies of Treg cells and parasite-specific CD8+ T cells in the spleen of mice shown in (F). In
(A) data are presented as mean ± SEM of n = 3–11 animals. In (B–D,F,G) each circle or dot represents one animal. In (C,F) the bars show the mean + SEM of each
parameter. Spearman r correlation coefficient and significance of the correlation are indicated inside the corresponding graphs. Data were pooled from 1 to 6
experiments according to the dpi and the determination. P-values were calculated by One way ANOVA with Dunnett’s multiple comparisons test in (A) and
Kruskal-Wallis with Dunn’s correction in (C,F). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001.
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FIGURE 3 | Limited expansion and reduced peripheral differentiation of Treg cells during acute T. cruzi infection. (A) Histograms for Ki-67 expression in Treg (CD4+
Foxp3+), Tconv (CD4+ Foxp3−) and total cells from the spleen of Foxp3-EGFP mice infected with T. cruzi at different dpi. Percentage of positive cells mean ± SEM
(n = 3–6 animals) and p-values are indicated for each dpi in comparison to 0 dpi. (B) Proliferation rate of cell populations at different dpi calculated as the relation
between % of Ki-67+ cells at 0 dpi and the other time points according to (A). (C) Histograms for Annexin V staining in 7-AAD− gated Treg, Tconv and total cells from
the spleen of T. cruzi infected Foxp3-EGFP mice at different dpi. Percentage of positive cells mean ± SEM (n = 3–6 animals) and p-values are indicated for each dpi.
(D) Apoptosis rate of cell populations at different dpi calculated as the relation between % of Annexin V+ cells at 0 dpi and the other time points according to (C). In
(B,D) statistics were performed by One Way ANOVA comparing Tconv and total cells rates to Treg cells rate at each dpi (Sidak’s multiple comparisons test). *P ≤ 0.05,
**P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001 and ns = not significant. (E–H) Tconv cells (CD4+ CD25− Foxp3-GFP−) from non-infected Foxp3-EGFP CD45.2 donors
(Continued)
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FIGURE 3 | were transferred into CD45.1 recipient mice, which were simultaneously infected with T. cruzi. Nineteen days after transfer, conversion of transferred cells
(GFP-) into Treg cells (GFP+) was assessed in different organs. Representative dot plots showing donor and host CD4+ cells according to CD45.2 and CD45.1
staining and Foxp3-GFP expression in CD45.2+ CD4+ donor cells in mLN from non-infected (NI) or infected (INF) hosts (E). Bar graphs depicting percentage (F) and
absolute numbers (G) of Treg cells within the population of transferred cells in different organs. Each circle represents one animal. Data were pooled from two
independent experiments. P-values were calculated by unpaired t-test. (H) Frequency of Treg cells (GFP+) determined within the CD4+ gate in cultures of purified
naïve CD4+ T cells or total splenocytes stimulated with coated anti-CD3 and anti-CD28 in the presence or absence of the Treg cell differentiation cocktail and live
parasites (at a cell:parasite ratio of 1:1 and 2:1) for 3 days. Data were pooled from two independent experiments with two technical replicates. P-values were
calculated by unpaired t-test.
consisted of pTreg cells while most of the exogenous cells in
mLN from infected mice were Tconv. The significant reduction
in the frequency of pTreg cells originated from the injected
Tconv during T. cruzi infection was observed not only in mLN
that have an environment prone for pTreg cell differentiation,
but also in the spleen and iLN (Figure 3F). To confirm that
induction of pTreg cells was inhibited during T. cruzi infection,
we calculated the absolute numbers of newly differentiated pTreg
cells in the different organs. In agreement with the frequency
data, the highest absolute numbers of induced pTreg cells were
found in mLN in comparison to other organs (Figure 3G). Of
note, the numbers of pTreg cells were significantly reduced in
mLN from infected mice in comparison to non-infected controls
but not in other organs. These data further support the notion
that differentiation of pTreg cells is reduced during T. cruzi
infection.
In order to identify mediators involved in the relative
decrease of Treg cells during T. cruzi infection, we focused
on particular inflammatory cytokines that are increased in the
course of this parasitic infection and/or have been reported to
modulate peripheral Treg cell proliferation and differentiation.
Among these mediators, we selected cytokines, such as IL-
6 and IL-1β that are produced during T. cruzi infection
[Supplementary Figure 2C and references (59, 60)] and have
been reported to restrain pTreg cell development by favoring a
Th17 fate (61, 62). Also, type I interferons increase early during
T. cruzi infection (63) and have been shown to limit regulatory
responses by reducing Treg cell proliferation (26) and peripheral
induction (64) in viral infection settings. We determined that
mice with deficient production of IL-6 due to deletion of the
Il6 gene (Il6−/−) or reduced IL-1β/IL-18 due to the lack of
Caspase1/11 (Casp1/11−/−) exhibited a similar decrease in Treg
cell frequency at 20 dpi when compared to WT mice. Similarly,
infected mice deficient in IFNAR, the specific receptor for type
I IFNs, also showed a relative reduction of Treg cell responses
(Supplementary Figure 3A). These results highlight that IL-6,
IL-1β, and type I IFN signaling were not responsible of the
relative Treg cell reduction triggered by T. cruzi infection.
As the frequency of Treg cells inversely correlated with
parasitemia (Figure 2B), we next speculated that parasites could
influence the size of the Treg cell pool during T. cruzi infection.
To gain further insights in this direction, we evaluated whether
changes in parasite levels as consequence of inoculation with
different parasite doses have any impact in the frequency of
Treg cells in periphery. We determined that 10-fold changes in
the parasite dose used for infection resulted in significant dose-
dependent differences in parasitemia at 11 dpi but not at 20 dpi,
when parasitemia reached a maximum that was independent on
the initial infective dose (Supplementary Figure 3B). Of note,
the frequency of splenic Treg cells at 11 dpi was inversely
associated with parasitemia and therefore remained unchanged
in mice infected with the lowest dose, that showed barely
detectable parasites in blood, but were significantly and dose-
dependently reduced in mice infected with the intermediate and
highest infective doses. These differences in Treg cell frequency
were no longer observed at 20 dpi, when all mouse groups
showed the same parasitemia (Supplementary Figure 3C). In
this context, we designed in vitro experiments aimed to evaluate
whether T. cruzi parasites are capable of inhibiting pTreg cell
induction. As shown in Figure 3H, most naïve CD4+ T cells
differentiated into iTreg cells when activated in the presence of
a Treg cell differentiation cocktail containing TFG-β, IL-2, and
all trans retinoic acid (atRA). Of note, live trypomastigotes were
unable to inhibit this differentiation. Similarly, more than 90%
of the CD4+ T cells became iTreg cells when total splenocytes
were activated in the presence of the Treg cell differentiation
cocktail. In contrast to the lack of effect on purified CD4+ T
cells, parasites significantly inhibited induction of iTreg cells in
cultures of total splenocytes. These results strongly suggest that
T. cruzi itself is able to actively inhibit Treg cell induction by an
indirect mechanism that may depend on accessory cells present
within the splenocytes rather than by a direct effect on naïve
CD4+ T cells.
Phenotypical and Transcriptional
Characterization of Treg Cells During T.
cruzi Infection Underscore a Specialization
in the Regulation of Type 1 Effector
Responses
The relative deficiency in the magnitude of Treg cell responses
during the course of T. cruzi infection may be compensated
by the activation and enhancement of the immunosuppressive
function of this subset as reported previously (65–67). To address
this, we performed a comprehensive evaluation of Treg cell
phenotype by flow cytometry, determining the expression of
proteins associated with Treg cell activation and suppressive
function, such as CD25, CTLA-4, GITR, CD39, CD73, LAG-
3, OX40, PD-1, FR4, GARP, TGF-β, and IL-10 together with
molecules involved in migration and effector/memory subset
classification like CD103, CD127, CCR7, CD44, and CD62L.
We also assessed markers of Th1 specialization including T-
bet, CXCR3 and IFN-γ in these cells. In order to broadly
interpret the phenotypic changes occurring in Treg cells during
Frontiers in Immunology | www.frontiersin.org 9 November 2018 | Volume 9 | Article 2555
Araujo Furlan et al. Treg Cells Dampen Parasite-Specific Immunity
FIGURE 4 | Treg cells show an activated phenotype and acquire a Th1-like profile during T. cruzi infection. (A) Plots of principal component analysis (PCA) for surface
and intracellular markers of Treg cells from the spleens of Foxp3-EGFP mice at the indicated dpi (left panel) and the variables included in PC1 and PC2 (right panel).
Each circle represents one animal. (B) Star plot displaying the expression of the indicated markers in Treg cells from non-infected (0 dpi, gray line) or infected (20 dpi,
red line) mice. Each spoke of the star represents the geometric mean of fluorescence intensity for the indicated marker in a log2 scale from 1 to 16,384. The data
length of a spoke is proportional to the MFI of expression of that marker in the corresponding sample. (C) Heat maps for the normalized expression scores (row mean
values of 0 and variance of 1) of genes encoding suppression and/or activation markers in Treg cells (CD4+ CD25+ Foxp3-GFP+) purified from the spleen of
non-infected (0 dpi) or 22-days-infected (22 dpi) Foxp3-EGFP mice. (D) Gene set enrichment analysis of the Treg cell transcriptome for Th1, Th2 and Th17 signatures
using selected gene sets. (E) Heat maps for the normalized expression scores (row mean values of 0 and variance of 1) of the selected genes used in (D). RNAseq
data are from one experiment with three biological replicates. The PCA plot, star plot and heat maps were created using InfoStat software, Microsoft Excel
spreadsheet and Matrix2png online tool, respectively.
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the progression of T. cruzi infection, we focused on changes
occuring in spleen and performed multivariate analysis of all the
markers evaluated. Principal component analysis (PCA) defined
two principal components (PC) that accounted for around 70%
of the total variance and allowed to evidence the phenotypic
changes suffered by Treg cells along the different dpi (Figure 4A,
left pannel). The variables included in PC1 and PC2 as well
as the direction of their changes are also depicted (Figure 4A,
right pannel). Interpretation of the PCA plots indicated that the
phenotype of Treg cells changed progressively from 0 dpi (non-
infected) until 20 dpi (maximal difference) by modifications in
the variables included mainly in PC1 and at a lower extent in
PC2. This analysis also established that Treg cells at 12 and 34 dpi
showed a similar phenotype that is intermediate between those of
cells from 0 and 20 dpi while Treg cells at 76 dpi showed features
more related to the phenotype of Treg cells from non-infected
mice (0 dpi).
The kinetics of expression of each marker highlighted that
Treg cells from T. cruzi infected mice exhibited phenotypic
changes as early as 12 dpi, with a maximum between 20
and 34 dpi (Supplementary Figure 4A). Of note, Treg cells
from 20-days infected mice showed an evident activated
phenotype as demonstrated by the upregulation of activation
and memory markers, such as Foxp3, CD25, OX40, CD103,
and CD127 in comparison to Treg cells from non-infected
mice (68). In addition, Treg cells at 20 dpi showed increased
expression of molecules associated with their suppressive
function including CTLA-4, GITR, CD39, and LAG-3 but
not CD73, PD-1, and FR4. We also established that Treg
cells increased their capacity to produce regulatory cytokines,
such as TGF-β (as indicated by co-expression of GARP and
LAP) and IL-10 (Supplementary Figure 4B) after 20 days of
infection. Finally, we determined that Treg cells at 20 dpi
upregulated CXCR3 and slightly T-bet, and increased IFN-γ
production in comparison to counterparts from non-infected
mice (0 dpi; Supplementary Figures 4C,D). Remarkably, T-bet
and CXCR3 expression levels in Treg cells from 20 dpi were
comparable and higher than those observed in Tconv cells at
the same time point, respectively (Supplementary Figure 4C).
The expression of several markers studied were represented in a
star plot that allowed to evidence differences in the phenotypic
profile of Treg cells at 0 and 20 dpi, showing that T. cruzi
infection induced the up-regulation of activation and Th1-
associated markers as well as immunosuppressive mediators
(Figure 4B).
In order to determine the global impact of T. cruzi infection
on the transcriptional program of Treg cells, we compared
by RNAseq the gene expression profiles of Treg cells purified
from the spleen at 0 and 20 dpi. A total of 5,175 genes were
differentially expressed in Treg cells as a consequence of T.
cruzi infection (data not shown). As illustrated by the heat maps
in Figure 4C, Treg cells from infected mice exhibited a global
increase in the levels of many transcripts encoding activation
markers and suppressive mediators. In addition to those noticed
by flow cytometry (CD25, CD127, CD103, GITR, CTLA-4, TGF-
β, and IL-10 among others), we also detected an up-regulation
of genes encoding ICOS, Granzyme B, CD137, TIGIT, Adenosin
A2a receptor, EBI3, Galectin-1, among others. In agreement
with their phenotypic profile, Treg cells from infected mice
showed reduced amounts of transcripts encoding CD44, PD-
1, CD62L, and CD73. Of note, Treg cells from infected mice
showed augmented levels in the expression of Blimp-1 and IRF4,
transcription factors that drive effector Treg cell differentiation
(67). Altogether, this transcriptional profile reflected a clear
activation of Treg cells along T. cruzi infection. Next, we aimed
to determine whether Treg cells from infected mice exhibit
programs that denote any functional specialization (69). To
this end, we performed Gene Set Enrichment Analysis of the
Treg cell transcriptome for Th1, Th2, and Th17 signatures.
As shown in the enrichment plots, the transcriptome of Treg
cells from infected mice are significantly enriched in the Th1,
Th2, and Th17 gene sets (Figure 4D). Interestingly, Treg cells
from T. cruzi infected mice up-regulated most of the genes
classically associated with a Th1 specialization including Tbx21,
Ifng, and Cxcr3 and also the two subunits of the IL-12 receptor
(Il12rb2 and Il12rb1), Stat1, Ifngr1, and Cxcl10 while they down-
regulated Il27ra (Figure 4E). Of note, Treg cells from infected
mice showed increased levels of some transcripts associated with
a Th2 signature, such as Il1r2, Il4ra, Il10, and Irf4 but not of
other prototypical Th2 genes, such as Gata3, Il4, Il5, or Il13.
Similarly, this cell subset showed increased expression of certain
genes associated with a Th17 fate like Rora, Stat3, Il21r, and
Ahr but not of others tightly linked to Th17 cells like Rorc and
Il17a.
Adoptive Transfer of Treg Cells Suppresses
Anti-Parasite Effector Response and
Diminishes Parasite Control During T. cruzi
Infection
Once established the features acquired by Treg cells after T.
cruzi infection, we aimed at evaluating the biological role of
this cell subset in the progression of the infection. Considering
the results from Figure 2, we were particularly interested in
addressing the relevance of the limited Treg cell response
for the induction/maintenance of effector responses and
immunopathology. To this end, we designed an experiment
in which Treg cell numbers were increased by the injection of
Treg cells differentiated in vitro (iTreg cells). iTreg cells were
obtained by sorting Foxp3-GFP+ cells from cultures in which
CD4+ T cells obtained from Foxp3-EGFP reporter mice were
stimulated with anti-CD3 and anti-CD28 in the presence of the
Treg cell differentiation cocktail (Supplementary Figure 5A).
In agreement with data showing that this cocktail induced
stable human iTreg cells (70), we determined that iTreg cells
generated in these conditions showed immunosuppressive
capacity in vitro (Supplementary Figure 5B), and failed
to produce effector cytokines, such as IFN-γ and IL-17
(Supplementary Figure 5C).
As schematized in Figure 5A, adoptive transfer experiments
were designed to inject iTreg cells into infected hosts at 11 dpi,
the time point in which the reduction of Treg cell frequency
becomes significant. Remarkably, infected hosts that received
iTreg cells showed significantly augmented levels of parasites
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FIGURE 5 | Adoptive transfer of Treg cells restricts the development of a robust parasite-specific CD8+ T cell response during acute T. cruzi infection. (A) CD45.1 WT
mice were infected with T. cruzi and 11 days later were transferred with 1 × 106 iTreg cells differentiated from Foxp3-EGFP mice. (B–C) Parasitemia [(B), left], parasite
load by real time PCR in the spleen and liver [(B), right] and glucose concentration in the plasma (C) of non-transferred control (INF) and transferred (INF + iTreg)
infected mice. (D–F) Dot plots (D) and graphs showing absolute numbers (E) of total and parasite-specific T cells responses in the spleen and liver of transferred and
control mice. Data are presented as mean + SEM and are pooled from two independent experiments. P-values were calculated by unpaired t-test (B,E) or Mann
Whitney test (C).
in blood and tissues in comparison to control counterparts
at 18 dpi (Figure 5B). In addition, and likely as consequence
of the uncontrolled parasite replication, mice injected with
iTreg cells presented reduced blood glucose concentration
but biochemical markers of tissue damage were not affected
(Figure 5C and data not shown). In order to establish the causes
of the reduced parasite control, we evaluated the magnitude
of the effector immune response. Adoptive transfer of iTreg
cells significantly diminished the frequency of parasite-specific
CD8+ T cells in spleen and liver of infected mice (Figure 5D).
Furthermore, the absolute numbers of parasite-specific CD8+
T cells and total CD8+ and CD4+ T cells were also reduced
after the injection of iTreg cells in infected hosts (Figure 5E).
Altogether, these results indicate that increasing Treg cell
numbers during T. cruzi infection severely compromises the
magnitude of protective immune responses including parasite-
specific CD8+ T cell immunity and consequently, limits the
control of parasite replication and host resistance to the
infection.
DISCUSSION
The role played by Treg cells in the progression of T.
cruzi infection remains controversial likely because any
rational mechanistic evaluation is precluded by the limited
characterization of the triggered Treg cell response. Considering
this, we studied in detail the kinetics of Treg cell responses using
Foxp3-EGFP reporter mice and demonstrated that frequency of
Treg cells is reduced along T. cruzi infection in most peripheral
organs including spleen, liver and inguinal lymph nodes.
Furthermore, we showed that this relative decrease is not caused
by a reduction in Treg cell absolute numbers but rather by a
significant expansion of effector cells that affect the ratio of Treg
cells to other immune subsets in different tissues. Thus, our
results further expand and complement a recent work reporting
that frequency of splenic Treg cells is significantly reduced
during acute experimental T. cruzi infection likely as result of a
neuroendocrine dysbalance (41). Altogether, this report and our
data underscore that, differently from most chronic infections of
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viral, bacterial and parasitic origin which are characterized by a
Treg cell accrual, T. cruzi infection associates with a significant
decrease in the magnitude of the Treg cell response that is
prolonged even until the early chronic phase of the infection.
After evaluating recognized mechanisms that regulate Treg
cell pool size in periphery, we established that Treg cells exhibited
significantly lower proliferation rate in comparison to effector
immune subsets during T. cruzi infection, confirming a previous
report in this direction (41). Although not surprising considering
the current views on pTreg cell induction (71), we also
demonstrated that the inflammatory environment triggered by
T. cruzi limits the peripheral induction of Treg cells. Remarkable,
infections characterized by Treg cell accumulation triggered a
marked proliferation of Treg cells but not peripheral induction
of this cell subset. Thus, influenza infection was shown to
induce peripheral proliferation and accumulation of Ag-specific
thymically derived Treg cells whereas conventional CD4+ T
cells with identical specificity for the pathogen underwent little
or no peripheral conversion in infected mice (72). Similarly,
Treg cells expressing a pathogen-specific transgenic TCR were
found to expand in response to M. tuberculosis without de novo
induction of pTreg cells (73). Of note, proliferation of Ag-
specific Treg cells was detected during M. tuberculosis but not
L. monocytogenes infection indicating that only certain microbes
are able to induce an inflammatory milieu that is conducive
to the expansion of Ag-specific Treg cells (74). In this context,
the results presented in our manuscript support the notion
that T. cruzi infection triggers a relatively deficient Treg cell
response by inducing an inflammatory context that does not
support pTreg cell induction (somehow expected as discussed)
but also limits Treg cell proliferation. Given that Treg cells
have a high dependence on exogenous IL-2 for differentiation
and proliferation, it is likely that Treg cell homeostasis may be
affected by the suppressed production or increased consumption
of IL-2 that occurs during T. cruzi infection (75–77). Indeed,
IL-2 consumption by proliferating effector cells resulted in
reduced Treg numbers in infections with Toxoplasma gondii,
Listeria monocytogenes, and vaccinia virus (25). In this regard, we
demonstrated that the systemic concentration of IL-2 remained
unchanged during the acute phase of T. cruzi infection and that
it showed no correlation with the frequency of splenic Treg
cells. In addition, Gonzalez et al (41) reported that treatment
with recombinant IL-2 was not sufficient to increase Treg cell
frequency during this parasitic infection. These data suggest that
regulation of the Treg cell pool size during T. cruzi infection is
independent from IL-2 levels.
Several pro-inflammatory mediators have been reported to
modulate Treg cell homeostasis during inflammatory conditions
(78). Among them, IL-1β and IL-6 emerged as possible
candidates to mediate the limited Treg cell response during T.
cruzi infection, given their largely known function to promote a
Th17 over a Treg cell fate (61, 62). We previously demonstrated
that Th17 and other IL-17+ cell subsets are induced early during
T. cruzi infection (79, 80) and when compared, the kinetics
of the increment in Th17 cell frequencies and the relative
decrease of Treg cells showed a reciprocal behavior (data not
shown). Also, type I IFNs may be involved in the limited
proliferation and induction of Treg cells as reported in viral
infections (26, 64). However, evaluation of the magnitude of
Treg cell responses in infected mice that lacked IL-6, IL-1β,
and type I IFNs signaling due to genetic deletions in Il6,
Caspase1/11, and Ifnar genes, respectively, ruled out a main
role for these pro-inflammatory cytokines in the regulation of
the Treg cell size during T. cruzi infection. Considering other
possible inflammatory mediators involved in this phenomenon;
we established that frequency of Treg cells showed a strong
inverse correlation with the levels of parasite in blood along
the infection. Furthermore, in vitro experiments indicated that
live parasites are able to inhibit the induction of Treg cells by a
mechanism that depends on cell populations other than CD4+ T
cells themselves. Altogether, these findings strongly suggest that
the T. cruzi load affects Treg cell peripheral induction and/or
proliferation by indirect mechanisms that are currently under
investigation in our laboratory.
Previous studies aimed at addressing the biological relevance
of Treg cells in the course of T. cruzi infection reported
contradictory results regarding the role of this subset in
the regulation of the magnitude and functionality of effector
immune responses, parasite control and development of
immunopathology. Thus, Treg cell depletion by treatment with
anti-CD25 depleting antibodies was reported to have a limited
role in the induction of parasite-specific CD8+ T cells, and
therefore, parasite control and host survival (43), but also to
slightly increase host resistance to infection by favoring activation
of CD4+ T cells (44). In contrast, combined injection of anti-
CD25 and anti-GITR evidenced that Treg cells may be important
to prevent exuberant inflammation, particularly at the heart, and
increased mortality during this parasitic infection (42). More
recently, early and sustained Treg cell depletion with anti-CD25
was reported to modulate Th1 and Th17 responses during T.
cruzi infection, reducing cardiac parasitosis and inflammation
(45). The reasons underlying these controversial data have not
yet been determined but may be related to the variability in
parasite and host strains, timing of Tregmanipulation and the use
of non-specific Treg cell depletion strategies. Considering these
data and our results demonstrating a limited Treg cell response
during T. cruzi infection, we reasoned that increasing Treg cell
numbers may be a more rational strategy to define the role of
Treg cells in this infection setting. Accordingly, we designed
adoptive transfer experiments in which Treg cell numbers were
manipulated by injection of in vitro differentiated Treg cells.
This approach has been widely used to modulate the outcome
of several pathological conditions including autoimmunity and
GVHD (81). We determined that increasing Treg cells at the
time when infected mice exhibited a significant reduction in
the frequency of this cell subset, limited the accumulation
of parasite-specific CD8+ T cells, severely compromising the
control of parasite replication in tissues and host resistance
to T. cruzi. These data are significant though they should be
interpreted with caution as the activation status of in vitro
generated Treg cells may enhance their suppressive function in
comparison to endogenous Treg cells as previously reported (82).
Even considering these limitations, our findings demonstrate
that activated Treg cells are able to dampen specific CD8+
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T cell immunity during T. cruzi infection. Furthermore, these
data suggest that the natural contraction of Treg cell responses
observed during the acute phase of T. cruzi infection may be
critical to allow the emergence of a robust effector response
aimed at controlling pathogen replication as previously reported
for acute infections (25). Thus, timing and other features of the
Treg cell response during this parasitic infection may evidence a
particular mechanism of a chronic T. cruzi-host adaptation that
allows the emergence of effector responses able to sustain partial
parasite control and host resistance but preventing complete
pathogen elimination.Within this conceptual framework, further
research will be required to address themechanisms involved and
to determine if a precise Treg cell manipulation may represent
an opportunity to potentiate anti-parasite immunity and parasite
control.
It is currently known that Treg cells exert their regulatory
function by deploying a plethora of immunosuppressive
mechanisms that target different immune cell populations. Treg
cells have been reported to modulate the activation, proliferation
and/or function of CD8+ and CD4+ T cells, B cells, NK cells,
monocytes and dendritic cells, among others (1). Altogether, the
phenotypic, transcriptional and functional profiles of Treg cells
activated during T. cruzi infection highlight the global activation
of this cell subset and also evidence a marked heterogeneity in the
Treg cell compartment from infected mice. Of note, even though
GSEA suggests that T. cruzi infection elicit Treg cell subsets that
acquire specialized programs for the regulation of Th1, Th2, and
Th17 responses, these cells showed a global up-regulation of most
of the genes classically associated to the Th1 signature but not of
those critical for Th2 and Th17 fates, such as Gata-3 and Rorγt.
Therefore, this specialized program may tailor Treg cells with
a particular ability to suppress in vivo type 1 effector responses
guiding Treg cells to Th1 inflammatory sites. Further studies
including single-cell RNA-seq may be very helpful to precisely
unravel the complexities of Treg cell responses during this
infection. By potentiating the regulatory response through iTreg
cell adoptive transfer, we established that Treg cells activated
in the context of T. cruzi infection have the ability to suppress
total and parasite-specific CD8+ T cell immunity and, at a minor
extent, the polyclonal CD4+ T cell response. Whether Treg cells
also influence other immune cell populations in these infectious
setting remains unexplored. Although not previously reported
for T. cruzi infection, Treg cell mediated suppression of CD8+
T cell immunity has been widely described during infections,
particularly of viral origin (13). Treg cells are able to regulate
many steps of the CD8+ T cell response through mechanisms
that remain partially elucidated and involve not only the CD8+
T cells themselves but also antigen presenting cells. In this way,
antigen-specific and polyclonal Treg cells impaired CD8+ T cell
priming by inhibiting the early expansion of antigen-specific
cells (83) and preventing the activation of antigen-presenting
cells through CTLA-4 mediated inhibitory signals (84). Even
more, Treg cells have been reported to directly limit CD8+
T cell proliferation (85), differentiation into effector cells (86),
cytotoxic effector function (87, 88) and to sustain CD8+ T cell
exhaustion (89) by mechanisms that involve IL-2 consumption,
TGF-β and IL-10 production, PD-1 and CD39 expression, and
many others. According to this, Treg cells activated in the context
of T. cruzi infection acquired a phenotypic profile that would
allow direct and indirect regulation of CD8+ T cell immunity.
In this regard, a direct suppressive function is supported by the
increased expression of CXCR3 in Treg cells activated during T.
cruzi infection that would allow migration to inflammatory sites.
In addition, a direct suppressive mechanism may be responsible
for the reduction in the magnitude of the specific CD8+ T cell
immunity that occur following iTreg cell adoptive transfer at
11 dpi, a time point after the emergence of the parasite-specific
CD8+ T cell response. On the other hand, the fact that Treg cells
activated during T. cruzi infection expressed remarkably high
levels of CTLA-4 may indicate that these cells are particularly
prepared for in vivo regulation of antigen-presenting cells. A
detailed comprehension of the mechanisms underlying the Treg
cell-mediated inhibition of CD8+ T cell immunity during this
parasitic infection will be essential to design possible immune-
intervention strategies aimed at improving parasite-specific
immunity without enhancing infection-associated pathology.
Altogether, our data delineate a model in which infection
with T. cruzi promotes activation but limits proliferation and
peripheral induction of Treg cells during the acute phase.
Whether these events are mediated by active mechanisms
remains to be clearly established as passive pathways are not
completely ruled out by our study. In any case, the Treg cell
mediated regulatory response seems to exhibit a putatively
improved quality but reduced quantity during T. cruzi infection.
This weakened Treg cell response allows the emergence of a
robust parasite-specific effector immunity, particularly of CD8+
T cells, which partially controls parasite replication favoring host
resistance. Although these findings support a deleterious role for
Treg cells during the acute phase of T. cruzi infection, a special
attention needs to be given to timing. Indeed, we also determined
that during the chronic phase, when parasite replication is limited
and inflammation goes down, the frequency and phenotypic
profile of Treg cells tended to return to normal conditions.
This finding together with reported data in which increased
Treg cell frequency and function in chagasic patients correlate
with better clinical outcomes, likely as consequence of a limited
chronic inflammation, proposes that Treg cell role may switch
during T. cruzi infection from deleterious in the acute phase to
protective during chronic Chagas disease. Further research will
be required to definitively address this point in order to establish
a rational framework for the design of novel treatment strategies
to differentially manipulate Treg cells during different stages of
T. cruzi infection.
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